Abstract: The present invention relates to an improved process for the racemization of (R)-3- (dimeth);lamino)-1-(2-thienyl)-l-propanol, an undesired enantiomer formed during synthesis of duloxetine hydrochloride, using an aqueous organic acid. The process according to present invention is safe, eco-friendly, high yielding and avoids use of highly corrosive acids.
| # | Name | Date |
|---|---|---|
| 1 | 2652-mum-2008-abstract.pdf | 2018-08-09 |
| 1 | 2652-mum-2008-form 5.pdf | 2018-08-09 |
| 2 | 2652-mum-2008-claims.pdf | 2018-08-09 |
| 2 | 2652-mum-2008-form 3.pdf | 2018-08-09 |
| 3 | 2652-mum-2008-correspondence.pdf | 2018-08-09 |
| 3 | 2652-mum-2008-form 2.pdf | 2018-08-09 |
| 4 | 2652-mum-2008-description(complete).pdf | 2018-08-09 |
| 4 | 2652-mum-2008-form 2(title page).pdf | 2018-08-09 |
| 5 | 2652-mum-2008-form 1.pdf | 2018-08-09 |
| 6 | 2652-mum-2008-description(complete).pdf | 2018-08-09 |
| 6 | 2652-mum-2008-form 2(title page).pdf | 2018-08-09 |
| 7 | 2652-mum-2008-correspondence.pdf | 2018-08-09 |
| 7 | 2652-mum-2008-form 2.pdf | 2018-08-09 |
| 8 | 2652-mum-2008-claims.pdf | 2018-08-09 |
| 8 | 2652-mum-2008-form 3.pdf | 2018-08-09 |
| 9 | 2652-mum-2008-abstract.pdf | 2018-08-09 |
| 9 | 2652-mum-2008-form 5.pdf | 2018-08-09 |